{"entity":{"type":"insider","cik":"0001307877","url":"/insider/0001307877","json_url":"/insider/0001307877.json","name":"Trellus Management Company, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":79,"n_filings":40,"first":"2009-04-21","last":"2011-05-26","span_basis":"filed_date"},"name_variants":[{"name":"Trellus Management Company, LLC","source":"filing","n_filings":40,"first_seen":"2009-04-21","last_seen":"2011-05-26"}],"transactions":[{"id":8992816,"accession":"0000947871-11-000529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-11-000529","line_url":"/filing/0000947871-11-000529#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1435000.0,"shares_display":"1,435,000","price_per_share":0.134,"price_display":"0.13","price_state":"stated","total_value":192290.0,"total_display":"192,290.00","total_whole":"192,290","shares_owned_after":18938485.0,"shares_owned_after_display":"18,938,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-25","filed_date":"2011-05-26","scope":"insider"},{"id":8992815,"accession":"0000947871-11-000529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000529","line_url":"/filing/0000947871-11-000529#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":0.1629,"price_display":"0.16","price_state":"stated","total_value":48870.0,"total_display":"48,870.00","total_whole":"48,870","shares_owned_after":20373485.0,"shares_owned_after_display":"20,373,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-24","filed_date":"2011-05-26","scope":"insider"},{"id":9147784,"accession":"0000947871-11-000388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-11-000388","line_url":"/filing/0000947871-11-000388#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":0.1362,"price_display":"0.14","price_state":"stated","total_value":27240.0,"total_display":"27,240.00","total_whole":"27,240","shares_owned_after":20673485.0,"shares_owned_after_display":"20,673,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-12","filed_date":"2011-04-12","scope":"insider"},{"id":9147783,"accession":"0000947871-11-000388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000388","line_url":"/filing/0000947871-11-000388#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310794.0,"shares_display":"310,794","price_per_share":0.0935,"price_display":"0.09","price_state":"stated","total_value":29059.239,"total_display":"29,059.24","total_whole":"29,059","shares_owned_after":20873485.0,"shares_owned_after_display":"20,873,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-12","scope":"insider"},{"id":9040250,"accession":"0000947871-11-000374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000374","line_url":"/filing/0000947871-11-000374#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Usdan Adam; Trellus Management Company, LLC","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187100.0,"shares_display":"187,100","price_per_share":0.0735,"price_display":"0.07","price_state":"stated","total_value":13751.85,"total_display":"13,751.85","total_whole":"13,752","shares_owned_after":21184279.0,"shares_owned_after_display":"21,184,279","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-04-06","filed_date":"2011-04-07","scope":"insider"},{"id":9010832,"accession":"0000947871-11-000369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000369","line_url":"/filing/0000947871-11-000369#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Management Company, LLC; Usdan Adam; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":0.084,"price_display":"0.08","price_state":"stated","total_value":3024.0,"total_display":"3,024.00","total_whole":"3,024","shares_owned_after":21371379.0,"shares_owned_after_display":"21,371,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-04-04","scope":"insider"},{"id":8878245,"accession":"0000947871-11-000129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-11-000129","line_url":"/filing/0000947871-11-000129#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; TRELLUS PARTNERS LP; Usdan Adam; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186314.0,"shares_display":"186,314","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":11178.84,"total_display":"11,178.84","total_whole":"11,179","shares_owned_after":21407379.0,"shares_owned_after_display":"21,407,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-24","scope":"insider"},{"id":8878243,"accession":"0000947871-11-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000129","line_url":"/filing/0000947871-11-000129#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; TRELLUS PARTNERS LP; Usdan Adam; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141084.0,"shares_display":"141,084","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":8465.04,"total_display":"8,465.04","total_whole":"8,465","shares_owned_after":21593693.0,"shares_owned_after_display":"21,593,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-23","filed_date":"2011-02-24","scope":"insider"},{"id":9147767,"accession":"0000947871-11-000026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-11-000026","line_url":"/filing/0000947871-11-000026#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC","owner_display_name":"Usdan Adam","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":0.0627,"price_display":"0.06","price_state":"stated","total_value":12540.0,"total_display":"12,540.00","total_whole":"12,540","shares_owned_after":21734777.0,"shares_owned_after_display":"21,734,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-01-11","filed_date":"2011-01-12","scope":"insider"},{"id":9147766,"accession":"0000947871-11-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-11-000026","line_url":"/filing/0000947871-11-000026","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC","owner_display_name":"Usdan Adam","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310794.0,"shares_display":"310,794","price_per_share":0.067545246047221,"price_display":"0.07","price_state":"stated","total_value":20992.6572,"total_display":"20,992.66","total_whole":"20,993","shares_owned_after":22054777.0,"shares_owned_after_display":"22,054,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-01-10","filed_date":"2011-01-12","scope":"insider","n_lines":2},{"id":8992812,"accession":"0000947871-11-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-11-000003","line_url":"/filing/0000947871-11-000003#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; TRELLUS PARTNERS II LP; Trellus Management Company, LLC; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Usdan Adam","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170000.0,"shares_display":"170,000","price_per_share":0.045,"price_display":"0.04","price_state":"stated","total_value":7650.0,"total_display":"7,650.00","total_whole":"7,650","shares_owned_after":22245571.0,"shares_owned_after_display":"22,245,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-30","filed_date":"2011-01-03","scope":"insider"},{"id":7520151,"accession":"0000947871-10-001131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-001131","line_url":"/filing/0000947871-10-001131#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Usdan Adam; TRELLUS PARTNERS LP; TRELLUS PARTNERS II LP; Trellus Management Company, LLC","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":0.0444,"price_display":"0.04","price_state":"stated","total_value":1465.2,"total_display":"1,465.20","total_whole":"1,465","shares_owned_after":22415571.0,"shares_owned_after_display":"22,415,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2010-12-21","scope":"insider"},{"id":7623962,"accession":"0000947871-10-001128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-001128","line_url":"/filing/0000947871-10-001128#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Usdan Adam; TRELLUS PARTNERS LP; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":0.045,"price_display":"0.04","price_state":"stated","total_value":765.0,"total_display":"765.00","total_whole":"765","shares_owned_after":22448571.0,"shares_owned_after_display":"22,448,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-15","filed_date":"2010-12-17","scope":"insider"},{"id":7315775,"accession":"0000947871-10-001103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-001103","line_url":"/filing/0000947871-10-001103#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":0.055,"price_display":"0.06","price_state":"stated","total_value":170.5,"total_display":"170.50","total_whole":"171","shares_owned_after":22465571.0,"shares_owned_after_display":"22,465,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-06","filed_date":"2010-12-08","scope":"insider"},{"id":7623961,"accession":"0000947871-10-001073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-001073","line_url":"/filing/0000947871-10-001073#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":0.0637,"price_display":"0.06","price_state":"stated","total_value":3822.0,"total_display":"3,822.00","total_whole":"3,822","shares_owned_after":22468671.0,"shares_owned_after_display":"22,468,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-18","filed_date":"2010-11-22","scope":"insider"},{"id":7700341,"accession":"0000947871-10-001070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-001070","line_url":"/filing/0000947871-10-001070#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd; TRELLUS PARTNERS II LP; TRELLUS PARTNERS LP","owner_display_name":"Usdan Adam","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26106.0,"shares_display":"26,106","price_per_share":0.05,"price_display":"0.05","price_state":"stated","total_value":1305.3,"total_display":"1,305.30","total_whole":"1,305","shares_owned_after":22528671.0,"shares_owned_after_display":"22,528,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-17","filed_date":"2010-11-18","scope":"insider"},{"id":7700340,"accession":"0000947871-10-001070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-001070","line_url":"/filing/0000947871-10-001070#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd; TRELLUS PARTNERS II LP; TRELLUS PARTNERS LP","owner_display_name":"Usdan Adam","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159178.0,"shares_display":"159,178","price_per_share":0.05,"price_display":"0.05","price_state":"stated","total_value":7958.9,"total_display":"7,958.90","total_whole":"7,959","shares_owned_after":22554777.0,"shares_owned_after_display":"22,554,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-16","filed_date":"2010-11-18","scope":"insider"},{"id":7557488,"accession":"0000947871-10-000981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000981","line_url":"/filing/0000947871-10-000981#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":120.0,"total_display":"120.00","total_whole":"120","shares_owned_after":22713955.0,"shares_owned_after_display":"22,713,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-07","filed_date":"2010-10-12","scope":"insider"},{"id":7478671,"accession":"0000947871-10-000975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000975","line_url":"/filing/0000947871-10-000975#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Usdan Adam; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Trellus Management Company, LLC","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":1440.0,"total_display":"1,440.00","total_whole":"1,440","shares_owned_after":22715955.0,"shares_owned_after_display":"22,715,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-06","filed_date":"2010-10-07","scope":"insider"},{"id":7478669,"accession":"0000947871-10-000975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000975","line_url":"/filing/0000947871-10-000975#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Usdan Adam; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Trellus Management Company, LLC","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2523.0,"shares_display":"2,523","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":151.38,"total_display":"151.38","total_whole":"151","shares_owned_after":22739955.0,"shares_owned_after_display":"22,739,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-05","filed_date":"2010-10-07","scope":"insider"},{"id":7700334,"accession":"0000947871-10-000974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000974","line_url":"/filing/0000947871-10-000974#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Management Company, LLC; Usdan Adam; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":660.0,"total_display":"660.00","total_whole":"660","shares_owned_after":22742478.0,"shares_owned_after_display":"22,742,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-04","filed_date":"2010-10-05","scope":"insider"},{"id":7700332,"accession":"0000947871-10-000974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000974","line_url":"/filing/0000947871-10-000974#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Management Company, LLC; Usdan Adam; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12700.0,"shares_display":"12,700","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":762.0,"total_display":"762.00","total_whole":"762","shares_owned_after":22753478.0,"shares_owned_after_display":"22,753,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-01","filed_date":"2010-10-05","scope":"insider"},{"id":7478667,"accession":"0000947871-10-000964","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-10-000964","line_url":"/filing/0000947871-10-000964#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":1440.0,"total_display":"1,440.00","total_whole":"1,440","shares_owned_after":22766178.0,"shares_owned_after_display":"22,766,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-29","filed_date":"2010-09-29","scope":"insider"},{"id":7478664,"accession":"0000947871-10-000964","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-10-000964","line_url":"/filing/0000947871-10-000964#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":1440.0,"total_display":"1,440.00","total_whole":"1,440","shares_owned_after":22790178.0,"shares_owned_after_display":"22,790,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-28","filed_date":"2010-09-29","scope":"insider"},{"id":7478662,"accession":"0000947871-10-000964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000964","line_url":"/filing/0000947871-10-000964#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188000.0,"shares_display":"188,000","price_per_share":0.0594,"price_display":"0.06","price_state":"stated","total_value":11167.2,"total_display":"11,167.20","total_whole":"11,167","shares_owned_after":22814178.0,"shares_owned_after_display":"22,814,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-27","filed_date":"2010-09-29","scope":"insider"},{"id":7478660,"accession":"0000947871-10-000964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000964","line_url":"/filing/0000947871-10-000964#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75180.0,"shares_display":"75,180","price_per_share":0.0908,"price_display":"0.09","price_state":"stated","total_value":6826.344,"total_display":"6,826.34","total_whole":"6,826","shares_owned_after":23002178.0,"shares_owned_after_display":"23,002,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-24","filed_date":"2010-09-29","scope":"insider"},{"id":7723448,"accession":"0000947871-10-000645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000645","line_url":"/filing/0000947871-10-000645#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Trellus Offshore Fund Ltd; Usdan Adam; TRELLUS PARTNERS II LP; TRELLUS PARTNERS LP","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85495.0,"shares_display":"85,495","price_per_share":0.0851,"price_display":"0.09","price_state":"stated","total_value":7275.6245,"total_display":"7,275.62","total_whole":"7,276","shares_owned_after":23077358.0,"shares_owned_after_display":"23,077,358","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-20","filed_date":"2010-05-26","scope":"insider"},{"id":7132176,"accession":"0000947871-10-000604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000604","line_url":"/filing/0000947871-10-000604#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP; Trellus Management Company, LLC","owner_display_name":"Usdan Adam","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.085,"price_display":"0.08","price_state":"stated","total_value":425.0,"total_display":"425.00","total_whole":"425","shares_owned_after":23162853.0,"shares_owned_after_display":"23,162,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-13","filed_date":"2010-05-17","scope":"insider"},{"id":7600696,"accession":"0000947871-10-000575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000575","line_url":"/filing/0000947871-10-000575#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; Trellus Management Company, LLC; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Usdan Adam","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27405.0,"shares_display":"27,405","price_per_share":0.085,"price_display":"0.08","price_state":"stated","total_value":2329.425,"total_display":"2,329.42","total_whole":"2,329","shares_owned_after":23167853.0,"shares_owned_after_display":"23,167,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-07","filed_date":"2010-05-11","scope":"insider"},{"id":7600693,"accession":"0000947871-10-000567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000567","line_url":"/filing/0000947871-10-000567#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd; TRELLUS PARTNERS LP","owner_display_name":"Usdan Adam","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":0.0849,"price_display":"0.08","price_state":"stated","total_value":42.45,"total_display":"42.45","total_whole":"42","shares_owned_after":23195258.0,"shares_owned_after_display":"23,195,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-04","filed_date":"2010-05-07","scope":"insider"},{"id":7723445,"accession":"0000947871-10-000553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000553","line_url":"/filing/0000947871-10-000553#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119219.0,"shares_display":"119,219","price_per_share":0.0822,"price_display":"0.08","price_state":"stated","total_value":9799.8018,"total_display":"9,799.80","total_whole":"9,800","shares_owned_after":23195758.0,"shares_owned_after_display":"23,195,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-30","filed_date":"2010-05-04","scope":"insider"},{"id":7723443,"accession":"0000947871-10-000553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000553","line_url":"/filing/0000947871-10-000553#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; Trellus Offshore Fund Ltd","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76800.0,"shares_display":"76,800","price_per_share":0.078,"price_display":"0.08","price_state":"stated","total_value":5990.4,"total_display":"5,990.40","total_whole":"5,990","shares_owned_after":23314977.0,"shares_owned_after_display":"23,314,977","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-29","filed_date":"2010-05-04","scope":"insider"},{"id":7189519,"accession":"0000947871-10-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000052","line_url":"/filing/0000947871-10-000052#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Trellus Offshore Fund Ltd; Usdan Adam; TRELLUS PARTNERS II LP","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25287.0,"shares_display":"25,287","price_per_share":0.105,"price_display":"0.10","price_state":"stated","total_value":2655.135,"total_display":"2,655.14","total_whole":"2,655","shares_owned_after":23391777.0,"shares_owned_after_display":"23,391,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-15","filed_date":"2010-01-20","scope":"insider"},{"id":7189517,"accession":"0000947871-10-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000052","line_url":"/filing/0000947871-10-000052#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Trellus Offshore Fund Ltd; Usdan Adam; TRELLUS PARTNERS II LP","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":165.0,"total_display":"165.00","total_whole":"165","shares_owned_after":23417064.0,"shares_owned_after_display":"23,417,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-14","filed_date":"2010-01-20","scope":"insider"},{"id":7520127,"accession":"0000947871-10-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000045","line_url":"/filing/0000947871-10-000045#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59900.0,"shares_display":"59,900","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":6589.0,"total_display":"6,589.00","total_whole":"6,589","shares_owned_after":23418564.0,"shares_owned_after_display":"23,418,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-11","filed_date":"2010-01-14","scope":"insider"},{"id":7520126,"accession":"0000947871-10-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000045","line_url":"/filing/0000947871-10-000045#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Usdan Adam; Trellus Offshore Fund Ltd; Trellus Management Company, LLC","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41100.0,"shares_display":"41,100","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":4521.0,"total_display":"4,521.00","total_whole":"4,521","shares_owned_after":23478464.0,"shares_owned_after_display":"23,478,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-08","filed_date":"2010-01-14","scope":"insider"},{"id":7151059,"accession":"0000947871-10-000033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-10-000033","line_url":"/filing/0000947871-10-000033#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158250.0,"shares_display":"158,250","price_per_share":0.1106,"price_display":"0.11","price_state":"stated","total_value":17502.45,"total_display":"17,502.45","total_whole":"17,502","shares_owned_after":23519564.0,"shares_owned_after_display":"23,519,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-01-08","scope":"insider"},{"id":7151058,"accession":"0000947871-10-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000033","line_url":"/filing/0000947871-10-000033#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138192.0,"shares_display":"138,192","price_per_share":0.1101,"price_display":"0.11","price_state":"stated","total_value":15214.9392,"total_display":"15,214.94","total_whole":"15,215","shares_owned_after":23677814.0,"shares_owned_after_display":"23,677,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-06","filed_date":"2010-01-08","scope":"insider"},{"id":7151056,"accession":"0000947871-10-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000033","line_url":"/filing/0000947871-10-000033#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Offshore Fund Ltd; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Usdan Adam","owner_display_name":"Trellus Offshore Fund Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173271.0,"shares_display":"173,271","price_per_share":0.1105,"price_display":"0.11","price_state":"stated","total_value":19146.4455,"total_display":"19,146.45","total_whole":"19,146","shares_owned_after":23816006.0,"shares_owned_after_display":"23,816,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-04","filed_date":"2010-01-08","scope":"insider"},{"id":7623932,"accession":"0000947871-10-000022","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-10-000022","line_url":"/filing/0000947871-10-000022#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; Usdan Adam","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":212500.0,"shares_display":"212,500","price_per_share":0.1101,"price_display":"0.11","price_state":"stated","total_value":23396.25,"total_display":"23,396.25","total_whole":"23,396","shares_owned_after":23989277.0,"shares_owned_after_display":"23,989,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-05","scope":"insider"},{"id":7623931,"accession":"0000947871-10-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-10-000022","line_url":"/filing/0000947871-10-000022#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; Usdan Adam","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80750.0,"shares_display":"80,750","price_per_share":0.1113,"price_display":"0.11","price_state":"stated","total_value":8987.475,"total_display":"8,987.48","total_whole":"8,987","shares_owned_after":24201777.0,"shares_owned_after_display":"24,201,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-30","filed_date":"2010-01-05","scope":"insider"},{"id":7623930,"accession":"0000947871-10-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-10-000022","line_url":"/filing/0000947871-10-000022#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; Usdan Adam","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39250.0,"shares_display":"39,250","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":4317.5,"total_display":"4,317.50","total_whole":"4,318","shares_owned_after":24282527.0,"shares_owned_after_display":"24,282,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-29","filed_date":"2010-01-05","scope":"insider"},{"id":7623929,"accession":"0000947871-10-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-10-000022","line_url":"/filing/0000947871-10-000022#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd; Trellus Management Company, LLC; Usdan Adam","owner_display_name":"TRELLUS PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":0.1115,"price_display":"0.11","price_state":"stated","total_value":8920.0,"total_display":"8,920.00","total_whole":"8,920","shares_owned_after":24321777.0,"shares_owned_after_display":"24,321,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2010-01-05","scope":"insider"},{"id":5910037,"accession":"0000947871-09-000811","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-09-000811","line_url":"/filing/0000947871-09-000811#line-5","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Usdan Adam; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":0.105,"price_display":"0.10","price_state":"stated","total_value":5775.0,"total_display":"5,775.00","total_whole":"5,775","shares_owned_after":24401777.0,"shares_owned_after_display":"24,401,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-23","scope":"insider"},{"id":5910035,"accession":"0000947871-09-000811","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-09-000811","line_url":"/filing/0000947871-09-000811#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Usdan Adam; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":0.1108,"price_display":"0.11","price_state":"stated","total_value":9418.0,"total_display":"9,418.00","total_whole":"9,418","shares_owned_after":24456777.0,"shares_owned_after_display":"24,456,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-23","scope":"insider"},{"id":5910033,"accession":"0000947871-09-000811","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-09-000811","line_url":"/filing/0000947871-09-000811#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Usdan Adam; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":1100.0,"total_display":"1,100.00","total_whole":"1,100","shares_owned_after":24541777.0,"shares_owned_after_display":"24,541,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-15","filed_date":"2009-12-23","scope":"insider"},{"id":5934493,"accession":"0000947871-09-000797","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-09-000797","line_url":"/filing/0000947871-09-000797#line-4","is_derivative":false,"issuer_cik":"0000812906","issuer_name":"HANCOCK FABRICS INC","issuer_ticker":"HKFI","issuer_name_source":null,"issuer_url":"/issuer/0000812906","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27400.0,"shares_display":"27,400","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":67404.0,"total_display":"67,404.00","total_whole":"67,404","shares_owned_after":2008400.0,"shares_owned_after_display":"2,008,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":5910031,"accession":"0000947871-09-000811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-09-000811","line_url":"/filing/0000947871-09-000811#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":null,"owner_name":"Trellus Management Company, LLC; Usdan Adam; TRELLUS PARTNERS LP; Trellus Offshore Fund Ltd","owner_display_name":"Trellus Management Company, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":0.11,"price_display":"0.11","price_state":"stated","total_value":3850.0,"total_display":"3,850.00","total_whole":"3,850","shares_owned_after":24551777.0,"shares_owned_after_display":"24,551,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-23","scope":"insider"},{"id":5934491,"accession":"0000947871-09-000797","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-09-000797","line_url":"/filing/0000947871-09-000797#line-3","is_derivative":false,"issuer_cik":"0000812906","issuer_name":"HANCOCK FABRICS INC","issuer_ticker":"HKFI","issuer_name_source":null,"issuer_url":"/issuer/0000812906","owner_cik":null,"owner_name":"TRELLUS PARTNERS LP; Usdan Adam; Trellus Management Company, LLC; TRELLUS PARTNERS II LP; Trellus Offshore Fund Ltd","owner_display_name":"TRELLUS PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85600.0,"shares_display":"85,600","price_per_share":2.4782,"price_display":"2.48","price_state":"stated","total_value":212133.92,"total_display":"212,133.92","total_whole":"212,134","shares_owned_after":2035800.0,"shares_owned_after_display":"2,035,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-11","filed_date":"2009-12-16","scope":"insider"}],"collapsed":true,"next_cursor":"2009-12-11|5934491","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /DE/","url":"/issuer/0001053369","role":"Ten percent owner","n_filings":39,"first_seen":"2009-04-21","last_seen":"2011-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000812906","name":"HANCOCK FABRICS INC","url":"/issuer/0000812906","role":"Ten percent owner","n_filings":1,"first_seen":"2009-12-16","last_seen":"2009-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001307877","retrieved_at":"2026-08-23T12:52:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}